Understand Inherited Blood Disorders with Advanced Genetic Testing
The Comprehensive Beta Globinopathy (HBB Gene Mutation & Deletion) – TRIO test is a specialized genetic analysis that evaluates the HBB (Beta Globin) gene in the patient and both biological parents. It detects both gene mutations and large deletions associated with beta globin disorders, helping provide an accurate diagnosis, inheritance pattern, and recurrence risk for future pregnancies.
Why is this test done?
Diagnose Beta Thalassemia and related hemoglobin disorders.
Identify disease-causing HBB gene mutations and deletions.
Confirm inheritance by analyzing the child and both parents (TRIO analysis).
Assess carrier status in family members.
Support genetic counseling and reproductive planning.
Who should consider this test?
Individuals with suspected Beta Thalassemia or unexplained anemia.
Children with abnormal hemoglobin screening results.
Couples with a family history of beta globin disorders.
Families seeking confirmation of inherited HBB gene variants.
Parents planning future pregnancies after an affected child.
Sample Required
Peripheral blood sample from the patient and both biological parents.
Key Benefits
Detects both point mutations and large gene deletions.
Higher diagnostic accuracy through TRIO-based analysis.
Helps determine whether variants are inherited or occur de novo.
Enables personalized genetic counseling and informed family planning.
Supports early diagnosis and appropriate clinical management.
Know your family's genetic risk with comprehensive HBB gene analysis. Early genetic insights can make a significant difference in diagnosis, treatment planning, and future healthcare decisions.